Aripiprazole API manufacturers

compare suppliers & send inquiries for free

Looking for Aripiprazole 129722-12-9?

Description:

Here you will find a list of producers, manufacturers and traders of Aripiprazole. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Aripiprazole 

Synonyms:

Abilify , Abilitat , Aripiprazol , Aripiprazole , Aripiprazolum , OPC 31 , 即 阿立 唑  

Cas Number:

129722-12-9 

DrugBank number:

DB01238 

Unique Ingredient Identifier:

82VFR53I78

Aripiprazole is a type of Atypical antipsychotics

Atypical antipsychotics belong to the subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various mental disorders, particularly schizophrenia and bipolar disorder. These medications are designed to alleviate the symptoms of psychosis by targeting specific neuroreceptors in the brain.

Unlike traditional antipsychotics, atypical antipsychotics exhibit a different pharmacological profile, providing a more favorable side effect profile and improved efficacy. These medications primarily act on dopamine and serotonin receptors, regulating the neurotransmitter levels in the brain to restore the chemical balance.

The mechanism of action of atypical antipsychotics involves blocking dopamine receptors, particularly D2 receptors, as well as modulating serotonin receptors, notably 5-HT2A receptors. By inhibiting excessive dopamine transmission and enhancing serotonin activity, atypical antipsychotics help reduce hallucinations, delusions, and other psychotic symptoms.

Some commonly used atypical antipsychotics include risperidone, olanzapine, quetiapine, and aripiprazole. These APIs are typically formulated into oral tablets or capsules for convenient administration.

Despite their effectiveness, atypical antipsychotics may have potential side effects such as weight gain, metabolic abnormalities, sedation, and extrapyramidal symptoms. Therefore, close monitoring and individualized treatment plans are essential to ensure optimal therapeutic outcomes.

In conclusion, atypical antipsychotics are a crucial subcategory of APIs used in the treatment of mental disorders. Their distinct pharmacological profile and mechanism of action make them valuable in managing psychosis while minimizing adverse effects.

Aripiprazole (Atypical antipsychotics), classified under Antipsychotics

Antipsychotics belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category used to treat psychiatric disorders such as schizophrenia, bipolar disorder, and other related conditions. These medications play a crucial role in managing symptoms associated with psychosis, including hallucinations, delusions, and disorganized thinking.

Antipsychotics work by modulating the levels of neurotransmitters in the brain, particularly dopamine and serotonin. They can be categorized into two classes: first-generation (typical) antipsychotics and second-generation (atypical) antipsychotics. Typical antipsychotics primarily target dopamine receptors, while atypical antipsychotics also affect serotonin receptors.

The pharmaceutical API category of antipsychotics includes various well-known drugs, such as haloperidol, chlorpromazine, risperidone, quetiapine, and olanzapine. These APIs are often formulated into different dosage forms, including tablets, capsules, injections, and oral suspensions, to provide flexibility in administration and patient-specific needs.

Antipsychotics offer relief from psychotic symptoms by stabilizing the imbalanced neurotransmitter activity in the brain. However, they may also have certain side effects, such as sedation, weight gain, extrapyramidal symptoms, and metabolic disturbances. It is essential for healthcare professionals to carefully monitor patients receiving antipsychotic treatment to optimize therapeutic benefits while minimizing adverse effects.

In summary, antipsychotics are a vital category of pharmaceutical APIs used to manage psychiatric disorders by modulating neurotransmitter activity in the brain. Their effectiveness in treating psychosis has made them a cornerstone of mental health treatment, providing much-needed relief to individuals suffering from these conditions.

• LGM Pharma from United States
• Nifty Labs from India
• Solfyn International LLP from India
• Duchefa Farma B.V. from Netherlands
• TIEFENBACHER API + Ingredients from Germany
• Gonane Pharma from India
• Cambrex from Italy
• HEC Pharm from Germany
• Sandoz from Austria
• Amoli Organics from India
• Chinoin from Hungary
• Centaur Pharma from India
• Harman Finochem from India
• Dishman Pharmaceuticals and Chemicals from India
• Pharmaceutical Solutions FZCO from United Arab Emirates
• Valdepharm (Groupe Fareva) from France
• Sharon Bio-Medicine from India
• Unichem Labs. from India
• Cadila Pharma from India
• Alkem Labs. from India
• Wockhardt from India
• Zhejiang Hisun Pharma from China
• Cadila Healthcare from India
• KRKA from Slovenia
• Teva API from Israel
• Ind-Swift Labs. from India
• Hetero Labs from India
• MSN Pharma from India
• Mylan from India
• Jubilant Generics from India
• Aurobindo from India
• Alembic Pharma from India
• Daewoong Bio from South Korea
• Erregierre from Italy
• Zhejiang Jinhua Conba from China
• Medichem from Spain
• Sun Pharma from India
• ZCL Chemicals from India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.